SciELO - Scientific Electronic Library Online

vol.13 suppl.1Essential parameters for use in epidemiological models of COVID-19 in Argentina: a rapid review author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand




  • Have no cited articlesCited by SciELO

Related links

  • Have no similar articlesSimilars in SciELO


Revista Argentina de Salud Pública

Print version ISSN 1852-8724On-line version ISSN 1853-810X


REINA, Rosa. Dexamethasone Treatment for Covid-19 Pneumonía. Rev. argent. salud pública [online]. 2021, vol.13, suppl.1, pp.1-1. ISSN 1852-8724.

Dexamethasone is currently one of the few treatments that has been shown to be effective in patients with modérate or severe SARS- CoV-2 pneumonia. A dose of 6 mg/day of dexamethasone base for 10 days has been shown to significantly reduce mortality in these patients. In Argentina, there are several commercial presentations of dexamethasone (dexamethasone sodium phosphate and dexamethasone phosphate acid). Therefore, it is important to know their equivalence in relation to dexamethasone base, in order to ensure the administration of 6 mg/day, that has been shown to decrease mortality.

Keywords : Dexamethasone; Respiratory Failure; COVID-19; Mortality; Argentina.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )